Krishna Institute of Medical Sciences Crescita futura
Future criteri di controllo 5/6
Krishna Institute of Medical Sciences prevede che gli utili e i ricavi cresceranno rispettivamente di 24.3% e 21.9% all'anno. Si prevede che l'EPS crescerà di 1.8% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 19.3% in 3 anni.
Informazioni chiave
24.3%
Tasso di crescita degli utili
1.8%
Tasso di crescita dell'EPS
Healthcare crescita degli utili | 27.3% |
Tasso di crescita dei ricavi | 21.9% |
Rendimento futuro del capitale proprio | 19.3% |
Copertura analitica | Good |
Ultimo aggiornamento | 21 Nov 2024 |
Aggiornamenti recenti sulla crescita futura
Krishna Institute of Medical Sciences Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Nov 13Krishna Institute of Medical Sciences Limited (NSE:KIMS) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Aug 10Krishna Institute of Medical Sciences Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Feb 08Recent updates
Krishna Institute of Medical Sciences Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Nov 13There's Reason For Concern Over Krishna Institute of Medical Sciences Limited's (NSE:KIMS) Massive 26% Price Jump
Sep 05We Think The Compensation For Krishna Institute of Medical Sciences Limited's (NSE:KIMS) CEO Looks About Right
Aug 23Krishna Institute of Medical Sciences Limited (NSE:KIMS) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Aug 10Is Krishna Institute of Medical Sciences (NSE:KIMS) Using Too Much Debt?
Jul 02Krishna Institute of Medical Sciences Limited's (NSE:KIMS) Shares May Have Run Too Fast Too Soon
Jun 12Is Now The Time To Put Krishna Institute of Medical Sciences (NSE:KIMS) On Your Watchlist?
Apr 28We Like These Underlying Return On Capital Trends At Krishna Institute of Medical Sciences (NSE:KIMS)
Apr 10Risks To Shareholder Returns Are Elevated At These Prices For Krishna Institute of Medical Sciences Limited (NSE:KIMS)
Feb 29Krishna Institute of Medical Sciences Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Feb 08Krishna Institute of Medical Sciences Limited (NSE:KIMS) Shares Could Be 34% Above Their Intrinsic Value Estimate
Jan 23Investors Will Want Krishna Institute of Medical Sciences' (NSE:KIMS) Growth In ROCE To Persist
Nov 21Do Krishna Institute of Medical Sciences' (NSE:KIMS) Earnings Warrant Your Attention?
Aug 23Returns Are Gaining Momentum At Krishna Institute of Medical Sciences (NSE:KIMS)
Aug 02Krishna Institute of Medical Sciences' (NSE:KIMS) Returns On Capital Are Heading Higher
Apr 01Krishna Institute of Medical Sciences (NSE:KIMS) Is Looking To Continue Growing Its Returns On Capital
Dec 14Analysts Have Made A Financial Statement On Krishna Institute of Medical Sciences Limited's (NSE:KIMS) First-Quarter Report
Aug 13Krishna Institute of Medical Sciences (NSE:KIMS) Is Investing Its Capital With Increasing Efficiency
Aug 12Here's Why Krishna Institute of Medical Sciences (NSE:KIMS) Has Caught The Eye Of Investors
Jul 02Krishna Institute of Medical Sciences Limited (NSE:KIMS) Investors Are Less Pessimistic Than Expected
May 08Previsioni di crescita degli utili e dei ricavi
Data | Ricavi | Guadagni | Flusso di cassa libero | Liquidità dell'operazione | Avg. Numero di analisti |
---|---|---|---|---|---|
3/31/2027 | 46,729 | 6,198 | 5,076 | 9,634 | 11 |
3/31/2026 | 38,186 | 4,632 | 2,565 | 7,600 | 13 |
3/31/2025 | 30,798 | 3,913 | -4,971 | 6,602 | 11 |
9/30/2024 | 27,053 | 3,313 | -2,409 | 4,964 | N/A |
6/30/2024 | 25,805 | 3,159 | N/A | N/A | N/A |
3/31/2024 | 24,981 | 3,101 | -1,262 | 5,211 | N/A |
12/31/2023 | 24,403 | 3,379 | N/A | N/A | N/A |
9/30/2023 | 23,966 | 3,421 | -2,263 | 4,621 | N/A |
6/30/2023 | 23,082 | 3,472 | N/A | N/A | N/A |
3/31/2023 | 21,977 | 3,363 | -1,424 | 4,321 | N/A |
12/31/2022 | 19,941 | 3,237 | N/A | N/A | N/A |
9/30/2022 | 18,255 | 3,289 | 741 | 3,693 | N/A |
6/30/2022 | 16,732 | 3,135 | N/A | N/A | N/A |
3/31/2022 | 16,508 | 3,327 | 1,537 | 3,240 | N/A |
12/31/2021 | 16,370 | 3,098 | N/A | N/A | N/A |
9/30/2021 | 16,041 | 2,774 | 2,318 | 3,488 | N/A |
6/30/2021 | 16,020 | 2,792 | N/A | N/A | N/A |
3/31/2021 | 13,299 | 2,012 | 2,615 | 3,560 | N/A |
12/31/2020 | 12,412 | 1,721 | 3,180 | 3,774 | N/A |
3/31/2020 | 11,227 | 1,192 | 1,495 | 2,015 | N/A |
3/31/2019 | 9,204 | -477 | 566 | 1,339 | N/A |
3/31/2018 | 6,652 | -474 | N/A | 1,058 | N/A |
3/31/2017 | 5,689 | 326 | N/A | 815 | N/A |
3/31/2016 | 5,145 | 266 | N/A | 955 | N/A |
3/31/2015 | 4,222 | 56 | N/A | 639 | N/A |
3/31/2014 | 3,569 | 69 | N/A | 778 | N/A |
Previsioni di crescita futura degli analisti
Guadagni vs tasso di risparmio: La crescita prevista degli utili di KIMS ( 24.3% all'anno) è superiore al tasso di risparmio ( 6.7% ).
Guadagni vs Mercato: Si prevede che gli utili di KIMS ( 24.3% all'anno) cresceranno più rapidamente del mercato Indian ( 18% all'anno).
Guadagni ad alta crescita: Si prevede che gli utili di KIMS cresceranno in modo significativo nei prossimi 3 anni.
Ricavi vs Mercato: Si prevede che il fatturato di KIMS ( 21.9% all'anno) crescerà più rapidamente del mercato Indian ( 10.5% all'anno).
Ricavi ad alta crescita: Si prevede che il fatturato di KIMS ( 21.9% all'anno) crescerà più rapidamente di 20% all'anno.
Previsioni di crescita dell'utile per azione
Rendimento futuro del capitale proprio
ROE futuro: Si prevede che il Return on Equity di KIMS sarà basso tra 3 anni ( 19.3 %).